Artificial Intelligence
Cognizant and NVIDIA Accelerate Drug Discovery with Generative AI
Cognizant (NASDAQ: CTSH) is advancing the application of generative AI (gen AI) technology with the NVIDIA BioNeMo platform to solve complex chal...
March 20, 2024 | News
BioGeometry and Sanyou Bio Announce Pioneering Alliance to Accelerate AI-Powered Antibody Research
BioGeometry, a frontrunner in digital biology and AI-driven protein design, alongside Sanyou Bio, a leading force in the high-tech biotechnology sector, ha...
March 19, 2024 | News
South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection
Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...
March 19, 2024 | News
EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices
Under the agreement signed on March 13, 2024, in Bellevue, Washington, EDAN and GH Labs will combine their expertise to create innovative ul...
March 18, 2024 | News
Lunit's Bid to Acquire Volpara Gains Momentum with New Zealand High Court's Initial Nod
Volpara Health Technologies (Volpara; ASX:VHT), renowned for its AI-driven solutions in cancer diagnostics, is on the brink of a transformative merger with...
March 14, 2024 | News
Novel Molecules From Generative AI to Phase II: Pioneering TNIK Inhibitors for Fibrotic Diseases
In a groundbreaking study published in Nature Biotechnology, Insilico Medicine, along with its collaborators, showcases the journey of INS018_055 f...
March 13, 2024 | News
CAIR Launches Revolutionary CARES Copilot 1.0, Elevating AI in Healthcare
The Centre for Artificial Intelligence and Robotics (CAIR), under the Hong Kong Institute of Science & Innovation, Chinese Acad...
March 12, 2024 | News
QIAGEN Advances Drug Discovery with AI-Driven Biomedical Knowledge Base Featuring 640 Million Relationships
QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-dr...
March 04, 2024 | News
VinBrain and Global Fund Partner to Fight Tuberculosis in Vietnam with AI in 2024
VinBrain is the sole entity chosen for this agreement with Global Fund in 2024. DrAid™ for TB Screening, a solution developed from VinBrain's in...
February 29, 2024 | News
Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") has announced a strategic partnership with the AI-driven company InveniAI...
February 22, 2024 | News
GSK Secures License for Elsie Biotechnologies' Cutting-Edge Discovery Platform
Kevin Green, Chief Operating Officer of Elsie Biotechnologies, expressed enthusiasm, stating, "We are pleased that GSK ha...
February 15, 2024 | News
VantAI and Bristol Myers Squibb Forge AI-Driven Partnership to Propel Molecular Glue Drug Discovery
VantAI, a trailblazer in artificial intelligence (AI)-enabled drug discovery, has announced a groundbreaking collaboration with pharmaceutical giant Bristo...
February 14, 2024 | News
Jiva.AI and Aevice Health Partner to Advance Medical AI for Asthma Prediction Using FDA-Cleared Remote Patient Monitor
The collaboration represents a synergistic blend of Jiva.ai's cutting-edge AI capabilities and Aevice Health's expertise in developing a proprietary ...
February 06, 2024 | News
ArteraAI Raises $20M to Enhance Personalized Cancer Therapy Using Multimodal AI
-ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced today that it has secured an ...
February 02, 2024 | News
Most Read
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
